|
     
|
Overview
Mountain View
Pharmaceuticals, Inc. (MVP) is a leader in the biopharmaceutical drug delivery
field. MVP seeks to improve drugs through the application of its polymer
coupling technology platforms and advanced analytical methods. Founded in
1995, the Company draws upon its base of pharmaceutical development, protein biochemistry,
immunology and polymer chemistry expertise in tackling the challenges to
effective drug delivery of cancer therapeutics. MVP's senior
management team members are
recognized leaders in their respective fields with many inventions
and publications to their
credit.
|
|
Technology
Benefits
MVP's technology platforms offer the following benefits:
|
 | Reduction
in the degradation and clearance rates of drugs (extension of
half-life) |
|
| Reduction
in the immunogenicity of drugs (prevention of antibody attack/ allergic
response) |
|
| More
favorable biodistribution of drugs (uptake by tumor or target tissue) |
|
| Improved
solubility and stability |
|
| Retained
activity in drugs (higher effective yield) |
|
| Increased
potency in vivo |
|
| Increased
drug therapeutic index (benefit/ toxicity) |
|
| MVP’s
methods for improving the overall performance of therapeutic agents have economic,
quality and regulatory advantages over other methods that are available from
competitors. |
[ Home ] [ Company ] [ Partnerships ] [ News ] [ Jobs ] [ Contact Us ]
|
